InsidersTradesSigma
Cronos Group Inc. Stock: price and management transactions · United States · SEC (Form 4)
Follow the Cronos Group Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Cronos Group Inc. has recorded 7 insider filings. Market capitalisation: €1bn. The latest transaction was disclosed on 14 May 2026 (Levée d'options). Among the most active insiders: Kenost Jared Matthew. Every trade is free.
7
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cronos Group Inc. Strong Buy (bullish), based on 1 analysts. Average price target: US$2.50.
14Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,716 of 26,180 companies
34.3
score / 100
Value33
Quality35
FCF yld-0.0%
Earn yld-0.9%
EV/EBITDA·
ROE0.5%
Gross mgn43%
Net mgn-6.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 14 May 2026
Declarations7 total
9,412 shares0COMMON SHARESSEC:0002103831-26-000004
10,367 shares0COMMON SHARESSEC:0002018799-26-000007
10,597 shares0COMMON SHARESSEC:0001923055-26-000008
8,806 sharesCOMMON SHARESSEC:0001656472-21-000055
12,977 sharesCOMMON SHARESSEC:0001656472-21-000053
28,287 sharesCOMMON SHARESSEC:0001656472-21-000054
2,739 sharesCOMMON SHARESSEC:0001656472-21-000056
7 of 7 declarations
About Cronos Group Inc.
Cronos Group Inc. is an international cannabinoid company listed on the NASDAQ under the ticker CRON, in the United States. The business is rooted in Canada, where it was founded and built around branded cannabis products, research-led product development, and international market expansion. Its principal executive presence is in Toronto, Ontario, and the company reports operations across several jurisdictions, most notably Canada and Israel, with additional growth ambitions in Europe. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001656472/000165647226000016/cron-20251231.htm?utm_source=openai)) From an equity analyst perspective, Cronos is best understood as a branded consumer cannabis platform rather than a pure upstream cultivator. Its portfolio includes Spinach®, PEACE NATURALS®, and Lord Jones®, with products spanning dried flower, vapes, gummies, pre-rolls, and other cannabis formats. The company also emphasizes innovation in cannabinoid-based formulations, including products enhanced with rare cannabinoids, which supports differentiation in a category that remains structurally competitive and price-sensitive. ([ir.thecronosgroup.com](https://ir.thecronosgroup.com/news-releases/news-release-details/cronos-unveils-new-spinachr-12g-vapes-and-sourz-spinachr-gummies/?utm_source=openai)) Cronos’ competitive position is strongest where brand equity and product innovation matter most. In Canada, Spinach has been particularly visible in vapes and edibles, while PEACE NATURALS has established itself as a leading medical cannabis brand in Israel. The company has also disclosed international commercialization efforts in markets such as Germany and the UK, reinforcing its positioning as a global cannabinoid company with multi-market optionality. ([ir.thecronosgroup.com](https://ir.thecronosgroup.com/news-releases/news-release-details/cronos-group-reports-2026-first-quarter-results/?utm_source=openai)) Recent developments have been centered on product launches and share gains. In 2025, Cronos expanded Spinach with new vape and gummy formats infused with rare cannabinoids, and into early 2026 it reported that Spinach had reached the number-one vape position in Canada, while several SOURZ by Spinach gummies ranked among the top-selling edible products nationally. The company also highlighted a pending acquisition in the Netherlands that could provide a strategic foothold in Europe and broaden its international footprint. ([ir.thecronosgroup.com](https://ir.thecronosgroup.com/news-releases/news-release-details/cronos-unveils-new-spinachr-12g-vapes-and-sourz-spinachr-gummies/?utm_source=openai)) Overall, Cronos Group is a specialized cannabis and cannabinoid name with meaningful brand assets, a multi-country footprint, and a NASDAQ listing in the United States. For investors, the key themes are execution in branded consumer products, international expansion, regulatory sensitivity, and the path toward sustained profitability and scale. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001656472/000165647226000016/cron-20251231.htm?utm_source=openai))
